Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Acuity | 1 | 2021 | 22 | 0.380 |
Why?
|
| Triage | 1 | 2021 | 111 | 0.350 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 259 | 0.290 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2017 | 92 | 0.270 |
Why?
|
| Mass Screening | 1 | 2021 | 651 | 0.260 |
Why?
|
| Positron-Emission Tomography | 2 | 2017 | 200 | 0.250 |
Why?
|
| Atherosclerosis | 2 | 2017 | 146 | 0.230 |
Why?
|
| Lipoproteins, LDL | 2 | 2021 | 45 | 0.210 |
Why?
|
| Macrophages | 2 | 2017 | 1015 | 0.180 |
Why?
|
| Proteasome Inhibitors | 1 | 2021 | 30 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 179 | 0.160 |
Why?
|
| Deoxyglucose | 1 | 2017 | 31 | 0.140 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 29 | 0.140 |
Why?
|
| Glutamine | 1 | 2017 | 46 | 0.140 |
Why?
|
| Monocytes | 2 | 2021 | 345 | 0.140 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2016 | 31 | 0.140 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 73 | 0.130 |
Why?
|
| Glucose | 2 | 2016 | 445 | 0.130 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 325 | 0.130 |
Why?
|
| 14-3-3 Proteins | 1 | 2014 | 19 | 0.110 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2014 | 62 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2014 | 279 | 0.100 |
Why?
|
| Medical Staff, Hospital | 1 | 2021 | 60 | 0.090 |
Why?
|
| Inflammation | 1 | 2016 | 1099 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2021 | 345 | 0.080 |
Why?
|
| Prevalence | 1 | 2021 | 1257 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5129 | 0.050 |
Why?
|
| Lipid Peroxides | 1 | 2021 | 11 | 0.050 |
Why?
|
| Boron Compounds | 1 | 2021 | 19 | 0.050 |
Why?
|
| Glycine | 1 | 2021 | 46 | 0.040 |
Why?
|
| Granulocytes | 1 | 2021 | 70 | 0.040 |
Why?
|
| Bortezomib | 1 | 2021 | 56 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2021 | 128 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2021 | 6081 | 0.040 |
Why?
|
| Mice | 3 | 2017 | 10300 | 0.040 |
Why?
|
| Autoradiography | 1 | 2017 | 53 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1368 | 0.030 |
Why?
|
| Aorta | 1 | 2017 | 108 | 0.030 |
Why?
|
| Aged | 1 | 2021 | 13426 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2016 | 181 | 0.030 |
Why?
|
| Middle Aged | 1 | 2021 | 16335 | 0.030 |
Why?
|
| Glutaredoxins | 1 | 2014 | 1 | 0.030 |
Why?
|
| Lim Kinases | 1 | 2014 | 3 | 0.030 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2014 | 4 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2014 | 33 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 54 | 0.030 |
Why?
|
| Glutathione | 1 | 2014 | 54 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2014 | 41 | 0.030 |
Why?
|
| Animals | 3 | 2017 | 19661 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 303 | 0.030 |
Why?
|
| Humans | 3 | 2021 | 59440 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 136 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 675 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2095 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 587 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 885 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1304 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 1137 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 1997 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2051 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 3621 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 2458 | 0.020 |
Why?
|
| Male | 1 | 2014 | 27775 | 0.010 |
Why?
|